Verifying…
Home / Drug A–Z / Gaviscon Double Action Liquid

Gaviscon Double Action Liquid

NAFDAC Reg. No. A4-9366 · Drug

Registered with NAFDAC. Registration activeAs of 27 October 2026 · synced automatically from official sources.
Product
Gaviscon Double Action Liquid
NAFDAC number
A4-9366
Active ingredient
Sodium alginate; Sodium bicarbonate; Calcium carbonate
Strength
250 mg/5 mL; 133.5 mg/5 mL; 80 mg/5 mL
Form
Suspension
Pack size
150 mL (in amber glass Winchester bottle)
Manufacturer
Not listed
Applicant (holder)
Reckitt Benckiser Nigeria Limited
Approved
31 Jul 2024
Status
Active View on NAFDAC ↗
Registration valid to
30 Jul 2029
WHO alerts
None found
Community reports
None
Times checked
0

What we found

  • Gaviscon Double Action Liquid is on the NAFDAC register with an active registration (A4-9366). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

What Gaviscon Double Action Liquid is used for

From the official U.S. FDA label for sodium alginate, the active ingredient registered with NAFDAC.

What it is used for

INDICATIONS: Aids in temporary relief of symptoms from exposure to household radiation such as headaches, difficulty sleeping, fatigue, muscle weakness and itchy skin.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Purpose

Aids in temporary relief of symptoms from exposure to household radiation such as headaches, difficulty sleeping, fatigue, muscle weakness and itchy skin.† †Claims based on traditional homeopathic pra …

Warnings

Professional Use Only If pregnant or breast-feeding, ask a health professional before use. In case of overdose, get medical help or contact a Poison Control Center right away. If condition worsens, seek medical attention. KEEP OUT OF REACH OF CHILDREN Do not use if tamper evident seal is broken or missing. Store in a cool place after opening

General information only, not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

Check your pack of Gaviscon Double Action Liquid

Add the expiry date on your pack for a full Trust Score.

3 free checks left today Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Gaviscon Double Action Liquid

What is in Gaviscon Double Action Liquid?

Gaviscon Double Action Liquid contains Sodium alginate; Sodium bicarbonate; Calcium carbonate (250 mg/5 mL; 133.5 mg/5 mL; 80 mg/5 mL), as suspension, according to its NAFDAC registration record.

Is Gaviscon Double Action Liquid registered with NAFDAC?

Yes. Gaviscon Double Action Liquid is listed on the NAFDAC register under registration number A4-9366, and its registration is active as of 27 October 2026.

Has Gaviscon Double Action Liquid been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Gaviscon Double Action Liquid in our automatically synced alert list.

How can I check that my pack of Gaviscon Double Action Liquid is genuine?

Run a free authenticity scan with the NAFDAC number A4-9366, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Gaviscon Double Action Liquid used for?

INDICATIONS: Aids in temporary relief of symptoms from exposure to household radiation such as headaches, difficulty sleeping, fatigue, muscle weakness and itchy skin.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. (Summarised from the official U.S. FDA label for sodium alginate. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Gaviscon Double Action Liquid? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.